CLIA lab like a Quest would pay AMBS to be the exclusive lab that runs tests for all the clinical trials under CLIA. That is what he has been talking about for end of summer. A JV partner, like a large BP, would commercialize Lympro after FDA approval for the general market. I wonder if a large BP with CLIA capabilities will sign end of summer for an all inclusive deal (CLIA and post FDA marketing) if they see the data and the potential.